Kushal Bhatia/LinkedIn
Apr 11, 2026, 13:37
Kushal Bhatia: Is The 4.5-Hour Thrombolysis Window Officially Outdated?
Kushal Bhatia, Consultant Neurosurgeon and Interventional Neurologist at Gleneagles Hospitals, shared on LinkedIn:
”Is the 4.5-hour thrombolysis window officially outdated?
A new JAMA RCT (OPTION trial) challenges our long-held boundaries.
In patients with non–large vessel stroke plus salvageable brain tissue, IV tenecteplase given up to 24 hours:
- Improved excellent outcomes (mRS 0–1)
- But increased symptomatic ICH
43.6% vs 34.2% — a meaningful shift.
The bigger message?
We are moving from a ‘time window’ to ’tissue window’ paradigm
For centers without thrombectomy access, this could be practice-changing.
Careful patient selection remains EVERYTHING.”
Stay updated with Hemostasis Today.
-
May 27, 2026, 17:51Nita Radhakrishnan: Post Graduate Institute of Child Health Receives WFH Data Quality Certification for Excellence
-
May 27, 2026, 17:51Fiona Robinson: What exactly Are Rebalancing Agents for Bleeding Aisorders?
-
May 27, 2026, 17:14Khurram Nasir: Can Earlier LDL-C Lowering Change the Trajectory of Cardiovascular Disease?
-
May 27, 2026, 17:09Yvonne Jongejan: Allele-Selective Silencing Therapy for VWD and Thrombotic Disorders
-
May 27, 2026, 16:58Catherine Moran: Important Step Forward as 1st WHO Resolution on Stroke Gets Adopted at WHA79
-
May 27, 2026, 16:08Heghine Khachatryan: Thrombosis in Oncology Remains a Major Healthcare Burden
-
May 27, 2026, 16:00Revealing Critical Gaps in Hemophilia Diagnosis and Access to Care in India – WFH
-
May 27, 2026, 16:00Melissa Hollo: Women Deserve Proactive Care, Not Reactive Care
-
May 27, 2026, 15:59Piotr Czempik: First Report of ROTEM Findings in Triple-Positive APS and Hageman Anomaly